跳至主要内容
临床试验/CTRI/2021/06/034067
CTRI/2021/06/034067尚未招募未知

A Randomized controlled clinical trial to evaluate efficacy between Krushna Churna and Parijatak Gugulu in the management of Gridhrasi.

PDEAs College of Ayurved and Research Centre Pradhikaran Nigdi Pune0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients showing classical symptoms and sign of Gridhrasi that is Padashoola (pain)
  • ,Katishoola (pain),Stambha (stiffness) ,Toda (pricking sensation) ,Spandan (twitching) , Dehasya â??Api-Pravakrata (Gait),Aruchi (Anorexia),Tandra (Drowsiness),Gaurav (Heaviness) as
  • described in ayurvedic samhitas in Charak Chikitsasthan 28/57,58. -
  • Radiating pain along the course and distribution of sciatic nerve that
  • is in buttock to outer border of foot.
  • 2. SLR Test of patient â?? positive upto 60 degree.
  • 3. Patients between the age of 25-65 years.
  • 4. Patients from all socio-economic status.

排除标准

  • 1. Pregnant and lactating mothers.
  • 2. Infective disorders â?? T.B. spine, osteomyelitis.
  • 3. Patients with paraplegia of lower limb.
  • 4. Fracture of spinal bones or in lower extremity bones
  • 5. Patients having congenital anamolies with lumbosacral spine
  • such as kyphosis, scolisis.
  • 6. Patients having any major chronic/acute; systemic/surgical pathology like malignancies.
  • 7. Patients with deep wounds penetrating till sciatic nerve.
  • 8. Patients with dislocation of hip joint, amputation above knee
  • 9. Patient having symptoms caused by prolonged pressure on hip
  • like comatosed patients.
  • 10.Patients having allergy to any content of drugs.
  • 11. High risk (above 65 years age, known cases of HTN, DM,COPD)
  • comorbid patients suspected for covid 19. Suspected covid 19
  • patient having symptoms as per ICMR guidelines.

研究者

发起方
PDEAs College of Ayurved and Research Centre Pradhikaran Nigdi Pune

相似试验